• Home
  • About
  • The Science
  • LCA16 Video
  • Team
  • Press
  • Contact Us
  • Home
  • About
  • The Science
  • LCA16 Video
  • Team
  • Press
  • Contact Us

LCA16 Video – Hubble TX Treatment

by Margo | Sep 22, 2025 | Videos

Andelyn Biosciences Selected by Hubble Therapeutics to Manufacture Clinical Grade AAV for the Treatment of Leber Congenital Amaurosis (LCA16)

by Margo | Oct 29, 2024 | Press Release

COLUMBUS, OH, October 9, 2024 – Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by Hubble Therapeutics, LLC,  to manufacture adeno-­associated virus...

Recent Posts

  • LCA16 Video – Hubble TX Treatment
  • Andelyn Biosciences Selected by Hubble Therapeutics to Manufacture Clinical Grade AAV for the Treatment of Leber Congenital Amaurosis (LCA16)

Recent Comments

  1. A WordPress Commenter on Andelyn Biosciences Selected by Hubble Therapeutics to Manufacture Clinical Grade AAV for the Treatment of Leber Congenital Amaurosis (LCA16)